NEW YORK (360Dx) – Vermillion said today it has entered into a contracted agreement with Blue Cross Blue Shield of Illinois for its OVA1 ovarian cancer test.

BCBS of Illinois is the largest PPO network in the state, covering roughly 7.9 million people.

"We are making considerable strides in expanding access to OVA1, said Fred Ferrara, Vermillion's chief operating officer. "Our increase in payer contracts will allow the majority of the population in the markets we serve to access OVA1."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.